`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`COALITION FOR AFFORDABLE DRUGS VII LLC
`Petitioner
`
`v.
`
`POZEN INC.
`Patent Owner
`______________
`
`Case No. IPR2015-01241
`Patent No. 6,926,907
`______________
`
`PATENT OWNER UPDATED EXHIBIT LIST
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Case No. IPR2015-01241
`Patent No. 6,926,907
`
`PATENT OWNER UPDATED EXHIBIT LIST
`
`EXHIBIT NO.
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`2011
`
`BRIEF DESCRIPTION
`License Agreement between Patent Owner Pozen Inc. and
`exclusive licensee Horizon Pharma, Inc.
`Norman & Hawkey, What you need to know when you
`prescribe a proton pump inhibitor, Frontline
`Gastroenterology, 1-7 (2011) (“Norman”)
`Comprehensive Pharmacy Review, Chapter 17: Drug
`Metabolism, Prodrugs, and Pharmacogenetics, 398-420
`(Leon Shargel et al. eds., 2010) (“Shargel”)
`Cederberg et al., Omeprazole: Pharmacokinetics and
`Metabolism in Man, Scand. J. of Gastroenterology 24:33-
`40 (1989) (“Cederberg”)
`Opinion in Astrazeneca AB v. Dr. Reddy’s Laboratories
`Inc., Nos. 11-2317 (JAP), 11-4275 (JAP), 11-6348 (JAP),
`filed on May 1, 2013 (“Claim Construction Order”)
`Fallingborg, Intraluminal pH of the human gastrointestinal
`tract, Danish Med. Bull. 46(3):183-96 (1999)
`(“Fallingborg”)
`Wolfe et al., Gastrointestinal Toxicity of Nonsteroidal
`Antiinflammatory Drugs, New England Journal of
`Medicine, 340(24):1888-99 (1999) (“Wolfe”)
`Stedman & Barclay, Review article: comparison of the
`pharmacokinetics, acid suppression and efficacy of proton
`pump inhibitors, Aliment Pharmacol. Ther. 14:963-78
`(2000) (“Stedman”)
`Bell & Hunt, Progress with Proton Pump Inhibition, Yale
`J. Biology & Med., 65:649-57 (1992) (“Bell”)
`Sachs et al., Review article: the control of gastric acid and
`Helicobacter pylori eradication, Aliment Pharmacol. Ther.
`14:1383-401 (2000) (“Sachs”)
`Letter from Donna Griebel, Food and Drug Administration
`to Paul Ossi, Pozen, Inc. (Nov. 6, 2008)
`
`
`
`
`
`
`
`Case No. IPR2015-01241
`Patent No. 6,926,907
`
`BRIEF DESCRIPTION
`Segal, Has Patent, Will Sue: An Alert to Corporate
`America, N.Y. Times (July 13, 2013), available at
`http://www.nytimes.com/2013/07/14/business/has-patent-
`will-sue-an-alert-to-corporate-america.html?_r=1 (“NY
`Times”)
`Walker & Copeland, New Hedge Fund Strategy: Dispute
`the Patent, Short the Stock, Wall Street Journal (Apr. 7,
`2015), available at http://www.wsj.com/articles/hedge-
`fund-manager-kyle-bass-challenges-jazz-pharmaceuticals-
`patent-1428417408 (“WSJ”)
`La Roche, Kyle Bass’ war against the US pharmaceutical
`industry has officially begun, Business Insider (Feb. 10,
`2015), available at http://www.businessinsider.com/kyle-
`bass-files-first-ipr-petition-2015-2 (“Bus. Insider”)
`Hayman Capital Management, L.P., Form ADV Part 2A
`Brochure (June 1, 2015) (“ADV”)
`Quinn, Senator Coons – Patents are about the American
`Dream, IPWatchdog.com (Mar. 5, 2015), available at
`http://www.ipwatchdog.com/2015/03/05/senator-coons-
`patents-are-about-the-american-dream/id=55442/
`(“IPWatchdog”)
`Bio Statement Following Kyle Bass’ IPR Petition,
`Biotechnology Industry Organization (Feb. 11, 2015),
`available at https://www.bio.org/media/press-release/bio-
`statement-following-kyle-bass-ipr-petition-0 (“Bio
`Statement 1”)
`America Invents Act, 157 Cong. Rec. S5319-03 (2011)
`H.R. Rep. No. 112-98, pt. 1 (2011)
`157 Cong. Rec. S5402-43 (Sept. 8, 2011)
`153 Cong. Rec. E773-75 (Apr. 18, 2007)
`112 Cong. Rec. S936-53 (Feb. 28, 2011)
`S. Rep. No. 110-259 (2008)
`Kyle Bass Continues Abuse of Patent Challenge System,
`Biotechnology Industry Organization (Sept. 3, 2015),
`available at https://www.bio.org/media/press-release/kyle-
`bass-continues-abuse-patent-challenge-system (“Bio
`Statement 2”)
`
`EXHIBIT NO.
`2012
`
`2013
`
`2014
`
`2015
`
`2016
`
`2017
`
`2018
`2019
`2020
`2021
`2022
`2023
`2024
`
`
`
`
`
`
`
`Case No. IPR2015-01241
`Patent No. 6,926,907
`
`Respectfully submitted,
`/s/ Ricardo Rodriguez
`Ricardo Rodriguez
`Reg. No. 40,789
`Counsel for Patent Owner
`
`
`BY:
`
`
`
`
`
`
`Date: September 18, 2015
`
`
`
`
`
`
`
`
`Case No. IPR2015-01241
`Patent No. 6,926,907
`
`CERTIFICATION OF SERVICE UNDER 37 C.F.R. § 42.6(e)
`
`I, Ricardo Rodriguez, hereby certify that on this 18th day of September
`
`
`
`
`
`2015, the foregoing Patent Owner Updated Exhibit List was served electronically
`
`via email on the following:
`
`Amy E. LaValle
`amy.lavalle@wickphillips.com
`
`Jerry C. Harris, Jr.
`jerry.harris@wickphillips.com
`
`CFAD.IPRs@wickphillips.com
`
`Wick Phillips Gould & Martin, LLP
`3131 McKinney Avenue, Suite 100
`Dallas, TX 75204
`
`
`BY:
`
`
`/s/ Ricardo Rodriguez
`Ricardo Rodriguez
`Reg. No. 40,789
`Counsel for Patent Owner
`
`
`
`
`
`Date: September 18, 2015